New Delhi, Feb. 20 -- India's Contract Research, Development, and Manufacturing Organization (CRDMO) industry is on a strong growth trajectory, with its market size expected to double from the current approx. USD 7 billion to approx. USD 14 billion by 2028, according to a report by Macquarie Equity Research.

The industry is projected to grow at a 14 per cent compound annual growth rate (CAGR), driven by rising pharmaceutical outsourcing, regulatory support, and global supply chain restructuring.

It said, "the Indian CRDMO industry, currently valued at around USD 7bn, is set to deliver a 14 pc CAGR to around USD 14bn by 2028. Furthermore, we believe that regulatory tailwinds, such as the US Biosecure Act, could accelerate this growth to ...